Evidence map›Paper›PMID 12151505›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2002

Orexin-A depolarizes dissociated rat area postrema neurons through activation of a nonselective cationic conductance.

Bo Yang, Alastair V Ferguson

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Orexin-A Intensifies Mouse Pupillary Light Response by Modulating Intrinsically Photosensitive Retinal Ganglion Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  3. Article
  4. Article
  5. Review
  6. The Neurobiology of Sleep and Wakefulness.The Psychiatric clinics of North America · 2015
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Evidence for the role of hindbrain orexin-1 receptors in the control of meal size.American journal of physiology. Regulatory, integrative and comparative physiology · 2011
    Article
  14. Article
  15. Article
  16. Area postrema neurons are modulated by the adipocyte hormone adiponectin.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  17. The subfornical organ: a central target for circulating feeding signals.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2006
    Article
  18. Hypocretin/orexin innervation and excitation of identified septohippocampal cholinergic neurons.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2004
    Article
  19. Excitatory effects of orexin-A on nucleus tractus solitarius neurons are mediated by phospholipase C and protein kinase C.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
  20. Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2003
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Bo YangDepartment of Physiology, Queen's University, Kingston, Ontario, Canada K7L 3N6.
Alastair V Ferguson
Queen's University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The area postrema (AP) is involved in the regulation of body fluid balance, feeding behavior, and cardiovascular function. Orexin (ORX)-A is a 33 aa peptide that regulates energy metabolism and sympathetic and cardiovascular actions. ORX immunoreactive axons and their varicose terminals have been found in AP. In this study, whole-cell, current- or voltage-clamp recordings were obtained from 108 dissociated rat AP neurons. The mean resting membrane potential of these neurons (n = 48) was -59.24 +/- 0.87 mV, the mean input resistance was 3.57 +/- 0.22 G(Omega), and the action potential amplitude of these cells was always >90 mV. Current-clamp studies showed bath application of ORX-A depolarized the majority of AP neurons tested (68.8%; 33 of 48), whereas small proportions of cells were either hyperpolarized (16.7%; 8 of 48) or unaffected (14.6%; 7 of 48). These depolarizing effects were found to be concentration dependent from 10(-8) to 10(-11) m. We then examined the contributions of specific ionic conductances to the ORX-A-induced excitation of AP neurons through whole-cell, voltage-clamp studies. Our results demonstrate that in contrast to previous studies on other neuronal populations, ORX-A did not affect net whole-cell potassium currents in AP neurons. Slow depolarizing voltage ramps, however, revealed that ORX-A enhanced a nonselective cationic conductance in AP neurons, effects which would explain the depolarizing effects of the peptide. These data demonstrate that AP neurons are directly influenced by ORX-A and suggest that ORX-A may exert its effects on the central control of feeding behavior and cardiovascular function through direct actions in AP.

Indexed as

Intracellular Signaling Peptides and ProteinsAnimalsCarrier ProteinsCationsCells, CulturedDose-Response Relationship, DrugFourth VentricleIon ChannelsMaleMembrane PotentialsNeuronsNeuropeptidesOrexinsPatch-Clamp TechniquesPotassiumRatsCarrier ProteinsCationsIntracellular Signaling Peptides and ProteinsIon ChannelsNeuropeptidesOrexinsPotassium

Identifiers

PMID12151505
PMCPMC6758169
OpenAlexW2122196568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.